WUXI, China, Feb. 25, 2024 /PRNewswire/ — BioCity Biopharma is pleased to announce the completion of enrollment of all 120 participants in the IgA nephropathy (IgAN) cohort in a randomized, double-blind, placebo-controlled Phase 2 clinical study of the novel, oral endothelin A…

PHILADELPHIA, Feb. 26, 2024 /PRNewswire/ — Berger Montague advises investors that a securities fraud class action lawsuit has been filed against B. Riley Financial, Inc. (“B. Riley” or the “Company”) (NASDAQ: RILY) on behalf of purchasers of B. Riley’s common stock between May 10, 2023…